Facebook Linkedin Twitter
Inside Precision Medicine Inflammatix Scores FDA Approval for Precision Infection Test

Rapid diagnostic test

Image showing bacteria next to blood cells in a blood vessel to illustrate what happens prior to sepsis setting in
Molecular Dx

Inflammatix Scores FDA Approval for Precision Infection Test

0
Tear drop
Molecular Dx

Tear Drop Test Is First Rapid, Point-of-Care Diagnostic for Parkinson’s Disease

0
Antibodies responding to COVID-19 coronavirus, illustration
Coronavirus

New COVID-19 Testing Method Can Potentially Catch Infections Just Hours after Exposure

0
Young Woman Coronavirus nasal Test
Coronavirus

Hong Kong Data Reveals Current COVID Vaccines Protect against Omicron, Briefly

0
Talis Biomedical has won up to $8.6 million in CARB-X funding toward developing pathogen identification and antibiotic susceptibility molecular diagnostics for chlamydia and gonorrhea. [CDC]
Molecular Dx

Talis Wins Up-to-$8.6M from CARB-X to Develop MDx for Infectious Diseases

0
Curetis plans to launch its Unyvero System (pictured) and Unyverso Lower Respiratory Tract Infection (LRT) Application Cartridge in the U.S. this quarter after the FDA granted the molecular diagnostic a De Novo clearance. [Curetis]
Molecular Dx

Curetis MDx Test for Lower Respiratory Tract Infection Wins FDA Clearance

0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine